GlassScriptPhysician profile
Rakesh P Mashru
NPI 1750318739
$51,814.14
in general payments reported to CMS, 2019-2025
8 companies · $4,102 in 2025
The $4,102 reported for 2025 was more than what 80% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,655 · 2020: $1,184 · 2021: $10K · 2022: $11K · 2023: $18K · 2024: $3,700 · 2025: $4,102.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $22K · Food and Beverage: $3,565 · Travel and Lodging: $380.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $22,185.00 |
| Food and Beverage | $3,564.56 |
| Travel and Lodging | $379.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $39,113.79 | 2019-2025 | T2 Alpha, Axsos, Pangea |
| Synthes USA Products LLC | $5,760.92 | 2021 | |
| Medical Device Business Services, INC. | $3,300.35 | 2021-2025 | Multiloc, Expert Nail, Tfn-Advance |
| Smith+Nephew, INC. | $1,906.69 | 2019-2022 | |
| Depuy Synthes Sales INC. | $1,439.02 | 2019-2025 | Va-Lcp, Na |
| Curvafix, INC. | $148.00 | 2022 | |
| Integra Lifesciences Corporation | $76.96 | 2022 | |
| Skeletal Dynamics INC | $68.41 | 2024-2025 | Ijs, Geminus, Implate |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rakesh Mashru listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.